Sartorius Accessia Pharma: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Sartorius Accessia Pharma
Largest movements
- Receivables within one year -€404,038
down €404,038 (-98.4%), from €410,808 to €6,770
- Tangible fixed assets -€301,542
down €301,542 (-5.1%), from €5.9m to €5.6m
of which Land and buildings: -€213,991
- Other debts -€907,543
down €907,543 (-73.4%), from €1.2m to €329,184
- Profit (loss) carried forward +€167,732
up €167,732 (+2.6%), from -€6.4m to -€6.2m
- Gross operating margin +€218,098
up €218,098 (+18.9%), from €1.2m to €1.4m
- Turnover +€165,262
up €165,262 (+8.1%), from €2.0m to €2.2m
- Purchases and services -€52,873
down €52,873 (-6.0%), from €885,425 to €832,552
- Staff costs +€40,660
up €40,660 (+18.0%), from €225,314 to €265,974
- Depreciation +€23,732
up €23,732 (+5.1%), from €466,661 to €490,393
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €6,354,521 | €5,648,342 | -€706,179 | -11.1% |
| Formation expenses | 20 | €445 | €0 | -€445 | -100% |
| Fixed assets | 21/28 | €5,923,101 | €5,621,559 | -€301,542 | -5.1% |
| Intangible fixed assets | 21 | €0 | €0 | = | |
| Tangible fixed assets | 22/27 | €5,923,101 | €5,621,559 | -€301,542 | -5.1% |
| Land and buildings | 22 | €5,619,997 | €5,406,006 | -€213,991 | -3.8% |
| Plant, machinery and equipment | 23 | €244,870 | €209,511 | -€35,359 | -14.4% |
| Furniture and vehicles | 24 | €9,789 | €6,042 | -€3,747 | -38.3% |
| Assets under construction and advance payments | 27 | €48,445 | €0 | -€48,445 | -100% |
| Current assets | 29/58 | €430,975 | €26,783 | -€404,192 | -93.8% |
| Amounts receivable within one year | 40/41 | €410,808 | €6,770 | -€404,038 | -98.4% |
| Trade receivables | 40 | €410,808 | €6,770 | -€404,038 | -98.4% |
| Cash at bank and in hand | 54/58 | €2,446 | €0 | -€2,446 | -100% |
| Deferred charges and accrued income | 490/1 | €17,721 | €20,013 | +€2,292 | +12.9% |
| Total equity and liabilities | 10/49 | €6,354,521 | €5,648,342 | -€706,179 | -11.1% |
| Equity | 10/15 | -€2,113,823 | -€1,966,117 | +€147,706 | +7.0% |
| Contributions | 10/11 | €4,100,000 | €4,100,000 | = | 0.0% |
| Capital | 10 | €4,100,000 | €4,100,000 | = | 0.0% |
| Issued capital | 100 | €4,100,000 | €4,100,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€6,375,303 | -€6,207,571 | +€167,732 | +2.6% |
| Investment grants | 15 | €161,480 | €141,454 | -€20,026 | -12.4% |
| Amounts payable | 17/49 | €8,468,344 | €7,614,459 | -€853,885 | -10.1% |
| Amounts payable after more than one year | 17 | €7,000,000 | €7,000,000 | = | 0.0% |
| Financial debts | 170/4 | €7,000,000 | €7,000,000 | = | 0.0% |
| Amounts payable within one year | 42/48 | €1,468,344 | €614,459 | -€853,885 | -58.2% |
| Trade debts | 44 | €112,107 | €146,530 | +€34,423 | +30.7% |
| Suppliers | 440/4 | €112,107 | €146,530 | +€34,423 | +30.7% |
| Taxes, remuneration and social security | 45 | €119,510 | €138,745 | +€19,235 | +16.1% |
| Taxes | 450/3 | €92,842 | €104,244 | +€11,402 | +12.3% |
| Remuneration and social security | 454/9 | €26,668 | €34,501 | +€7,833 | +29.4% |
| Other amounts payable | 47/48 | €1,236,727 | €329,184 | -€907,543 | -73.4% |
| Turnover | 70 | €2,039,211 | €2,204,473 | +€165,262 | +8.1% |
| Non-recurring operating income | 76A | €0 | - | = | |
| Goods, raw materials, services and sundry goods | 60/61 | €885,425 | €832,552 | -€52,873 | -6.0% |
| Remuneration, social security and pensions | 62 | €225,314 | €265,974 | +€40,660 | +18.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €466,661 | €490,393 | +€23,732 | +5.1% |
| Other operating charges | 640/8 | €77,283 | €74,925 | -€2,358 | -3.1% |
| Non-recurring operating charges | 66A | - | €35,000 | +€35,000 | |
| Gross operating margin | 9900 | €1,155,524 | €1,373,622 | +€218,098 | +18.9% |
| Operating profit (loss) | 9901 | €386,266 | €507,330 | +€121,064 | +31.3% |
| Financial income | 75/76B | €20,026 | €20,026 | = | 0.0% |
| Recurring financial income | 75 | €20,026 | €20,026 | = | 0.0% |
| Financial charges | 65/66B | €368,074 | €359,624 | -€8,450 | -2.3% |
| Recurring financial charges | 65 | €368,074 | €359,624 | -€8,450 | -2.3% |
| Profit (loss) for the period before taxes | 9903 | €38,218 | €167,732 | +€129,514 | +339% |
| Profit (loss) for the period | 9904 | €38,218 | €167,732 | +€129,514 | +339% |
| Profit (loss) for the period to be appropriated | 9905 | €38,218 | €167,732 | +€129,514 | +339% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 20 October 2026 via checked.be.